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Evaluation of an ethidium monoazide–enhanced 16S rDNA
real-time polymerase chain reaction assay for bacterial screening
of platelet concentrates and comparison with automated culture
Jeremy A. Garson,* Poorvi Patel,* Carl McDonald, Joanne Ball, Gillian Rosenberg, Kate I. Tettmar,
Susan R. Brailsford, Tyrone Pitt, and Richard S. Tedder
BACKGROUND: Culture-based systems are currently
the preferred means for bacterial screening of platelet
(PLT) concentrates. Alternative bacterial detection tech-
niques based on nucleic acid amplification have also
been developed but these have yet to be fully evalu-
ated. In this study we evaluate a novel 16S rDNA poly-
merase chain reaction (PCR) assay and compare its
performance with automated culture.
STUDY DESIGN AND METHODS: A total of 2050 time-
expired, 176 fresh, and 400 initial-reactive PLT packs
were tested by real-time PCR using broadly reactive
16S primers and a “universal” probe (TaqMan, Invitro-
gen). PLTs were also tested using a microbial detection
system (BacT/ALERT, bioMérieux) under aerobic and
anaerobic conditions.
RESULTS: Seven of 2050 (0.34%) time-expired PLTs
were found repeat reactive by PCR on the initial nucleic
acid extract but none of these was confirmed positive
on testing frozen second aliquots. BacT/ALERT testing
also failed to confirm any time-expired PLTs positive on
repeat testing, although 0.24% were reactive on the first
test. Three of the 400 “initial-reactive” PLT packs were
found by both PCR and BacT/ALERT to be contami-
nated (Escherichia coli, Listeria monocytogenes, and
Streptococcus vestibularis identified) and 14 additional
packs were confirmed positive by BacT/ALERT only. In
13 of these cases the contaminating organisms were
identified as anaerobic skin or oral commensals and the
remaining pack was contaminated with Streptococcus
pneumoniae.
CONCLUSION: These results demonstrate that the 16S
PCR assay is less sensitive than BacT/ALERT and
inappropriate for early testing of concentrates. However,
rapid PCR assays such as this may be suitable for a
strategy of late or prerelease testing.
T
ransfusion-transmitted bacterial infection
remains an unresolved problem associated with
significant morbidity and mortality.1 Bacterial
contamination of platelets (PLTs) is responsible
for most cases of blood component associated sepsis and
globally the reported prevalence of such contamination
ranges from 0.03% to 0.7%.2,3 PLTs pose the greatest risk
because, to preserve their function, they are stored at 22 to
24°C with constant agitation. These storage conditions
provide for the majority of contaminating bacteria an
excellent growth environment, so that small numbers of
organisms may rapidly increase to levels likely to cause
sepsis.4
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In an effort to address this problem many countries
have introduced bacterial screening of PLT concentrates
by culture-based methods. Automated culture systems
such as the BacT/ALERT 3D microbial detection system
(bioMérieux UK Ltd, Basingstoke, Hampshire, UK) are
widely used for this purpose.5 However, the use of culture
systemsmay result in the transfusion of a PLT component
before the determination of a positive result.6 This is par-
ticularly likely with slow-growing organisms and very low
initial bacterial loads.7,8 Despite the use of such culture
methods, and the introduction of improved skin decon-
tamination techniques and diversion pouches,6 the
residual risk of PLT transfusion-transmitted sepsis is esti-
mated to be in the region of 1 in 45,000 to 90,000.7,9
Recognition of the limitations of slow, culture-based
screening methods has encouraged the development of
more rapid detection technologies including immuno-
logic assays (PGD, Pan Genera Detection system, Verax
Biomedical, Inc., Marlborough, MA), flow cytometry (Bac-
tiFlow, AES Chemunex GmbH, Bruchsal, Germany), and
polymerase chain reaction (PCR) amplification of bacte-
rial nucleic acid.10 The strengths and weaknesses of these
alternative technologies have been reviewed by others10-12
and key performance characteristics are summarized in
Table 1. Although PCR-based methods may be more
technically demanding than alternative rapid detection
techniques they potentially offer assays with greater
sensitivity.
The most widely used target for PCR assays is the
highly conserved 16S ribosomal RNA gene (16S rDNA)
which is present as multiple copies in all bacterial
genomes.14,15 Theoretically, PCR-based assays should be
capable of detecting single molecules of 16S rDNA and
therefore achieve extremely high sensitivity but this
potential has not generally been realized.Themain reason
for the disappointing performance ofmost 16S PCR assays
is the ubiquitous presence of low-level contaminating
bacterial DNA in laboratory consumables and PCR
reagents, particularly in Taq polymerases.16
Numerous approaches to PCR reagent decontamina-
tion have been described17-21 but most have proven inef-
fective or unreliable in subsequent studies.22,23We recently
compared the effectiveness of several different reagent
decontamination techniques and found that all but one of
them failed to achieve the level of decontamination
required. The single successful method employed
ethidium monoazide (EMA) treatment of the PCR master
mix followed by photoactivation, which totally eliminated
bacterial DNA contamination without compromising
assay sensitivity. The optimized assay was shown to be
capable of detecting a wide range of organisms known to
be associated with contamination of PLT concentrates, at
levels down to approximately 1 colony-forming unit
(CFU)/mL.24 In this study, we evaluate the performance of
this EMA-enhanced real-time 16S rDNA PCR for screening
of PLT concentrates in parallel with BacT/ALERT
automated culture. In February 2011, National Health
Service Blood and Transplant (NHSBT) implemented the
screen testing of all PLT components using the BacT/
ALERT system.25
MATERIALS AND METHODS
NHSBT bacterial screening procedure
PLT components were sampled between 36 and 48 hours
from collection. Aerobic and anaerobic culture was per-
formed with 8 mL inoculated per culture bottle. Bottles
were incubated at 36°C for the remainder of the 7-day
shelf life of the component. All initial-reactive bottles and
components were sent to NHSBT National Bacteriology
Laboratory for confirmatory and reference work.
Time-expired PLTs
Leukoreduced PLTs were prepared according to standard
NHSBT procedures. Of the 2050 time-expired PLTs tested
745 were pooled and buffy coat derived and 1305 were
apheresis components. Pooled PLTs were prepared by
pooling the buffy coats from four whole blood donations
and resuspending in approximately 250 mL ofmale donor
plasma. CPD anticoagulant was used and PLT concen-
trates were stored at 22°C with agitation. For apheresis
PLTs the anticoagulant used was ACD. Each unit con-
tained more than 2.4 ¥ 1011 PLTs and fewer than 5 ¥ 106
TABLE 1. Key features of assays available for detecting bacterial contamination of PLT concentrates
(data derived from publications10-13)
Assay type
Sensitivity
CFUs/mL* Assay time
Sample
volume (mL)
Technical
complexity†
Early testing
strategy‡
Late testing
strategy§
BacT/ALERT culture system 1-10 1-7 days 8-16 Medium Yes No
PGD (Verax) immunoassay 104-106 1.5 hr 0.5 Low No Yes
BactiFlow flow cytometry >150 1 hr 1 Medium No Yes
PCR nucleic acid amplification 10-30 3-4 hr 0.2-2 High ? Yes
* Approximate ranges; sensitivity varies according to bacterial species, assay protocol, and so forth.
† Technical complexity is associated with requirement for highly skilled laboratory personnel.
‡ Potential suitability of assay for early testing after preincubation period and release on a negative-to-date basis.
§ Potential suitability of assay for late testing strategy (e.g., prerelease testing).
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white blood cells. PLT concentrates were defined as “time-
expired” at 7 days postdonation (note that before the
introduction by NHSBT of BacT/ALERT screening the
shelf-life for PLTs was 5 days). The 2050 time-expired PLT
concentrates were tested by EMA-enhanced 16S rDNA
real-time PCR assay and in parallel by the BacT/ALERT
automated culture system. All time-expired PLTs were col-
lected from blood donors in England and processed and
manufactured at NHSBT sites in Bristol, Sheffield,
Manchester, Brentwood, and London (Colindale) during
the period July 2010 to October 2011.
Fresh PLTs
In addition to the 2050 time-expired PLTs, 176 “fresh” PLTs
(i.e., prepared and tested on the day of donation) were also
tested by EMA-enhanced 16S rDNA real-time PCR assay.
All fresh PLTs were donated in England and processed by
NHSBT at the Colindale site between March and April
2012.
Initial-reactive PLTs
The term “initial reactive” is used in this study to refer to
PLTs that were flagged as reactive by BacT/ALERT on
initial testing at NHSBT laboratories in Bristol, Sheffield,
Manchester, Newcastle, and Colindale during the period
November 2011 to February 2012. Four-hundred initial-
reactive PLT packs were transferred at 4°C to the NHSBT
National Bacteriology Laboratory at Colindale for confir-
matory and reference work, which included retesting by
BacT/ALERT automated culture and for analysis by EMA-
enhanced 16S rDNA real-time PCR.
Automated nucleic acid extraction
Nucleic acidwas extracted fromPLT concentrates using an
automated high-throughput platform (MagNA Pure 96
system with MagNA Pure 96 DNA and Viral NA small
volume kit reagents, Roche Diagnostics Ltd, Burgess Hill,
West Sussex, UK) previously shown to be capable of
producing uncontaminated extracts.24 Manipulations
were performed in a Class II biological safety cabinet
andsteriledisposableplasticware (aerosol-resistant,DNA-
free pipette tips, Rainin BioClean GP-10F and GP-20F,
Anachem Ltd, Bedfordshire, UK) was employed through-
out. Two milliliters of PLT concentrate was centrifuged at
10,000 ¥ g for 5minutes and the pellet was resuspended in
200 mL of supernatant. The resuspended pellet was then
frozen at -20°C and rethawed at room temperature before
nucleic acid extraction on the MagNA Pure 96 platform as
per manufacturer’s instructions. The elution volume was
50 mL. A second 2-mL aliquot of each PLT concentrate was
also centrifuged as described above and the resuspended
pellet stored frozen at -20°C to be used to confirm any
positive result arising from PCR testing of the first aliquot.
EMA-enhanced 16S rDNA real-time PCR assay
Universal primers and TaqMan probe were used to
amplify and detect a highly conserved 160-bp region of
the bacterial 16S rDNA gene in a 25-mLmultiplex PCR also
containing internal control human mitochondrial DNA
(mtDNA) primers and probe. Full sequence details of
the primers (16S-F, 16S-R, Propioni-F, Bacteroides-R,
mtDNA-F, mtDNA-R) and probes (16S-Probe, mtDNA-
Probe) have been published previously.24 All oligonucle-
otides were synthesized by Applied Biosystems
(Warrington, UK). PCR master mix contained 1¥ PCR
buffer (Qiagen, Crawley, West Sussex, UK; HotStarTaq
buffer), 3.0 mmol/L MgCl2, 0.2 mmol/L each dNTP (Invit-
rogen, Life Technologies Ltd, Paisley, UK), 400 nmol/L
each 16S-F and 16S-R, 200 nmol/L 16S-Probe, 300 nmol/L
Propioni-F, 200 nmol/L Bacteroides-R, 20 nmol/L each
mtDNA-F and mtDNA-R, 100 nmol/L mtDNA-Probe,
0.625 U HotStarTaq polymerase (Qiagen) per 20 mL,
and 1.2 mmol/L EMA (Biotium, Inc., Hayward, CA). All
manipulations involving EMA, before and including the
photoactivation step, were performed in a dark room
under red safelight illumination as described previously.24
The PCRmastermixwas placed on ice in a closed polypro-
pylene microtube (Sarstedt Ltd, Leicester, UK; catalogue
no. 72.692.005) and exposed to a 500-W halogen light
source (bulb type R7s, Powerlight Ltd, Leeds, UK) for 3
minutes at a distance of 20 cm. After photoactivation, the
EMA-treated PCRmaster mix was aliquoted into the wells
(20 mL per well) of a 96-well optical plate (Applied Biosys-
tems, catalogue no. 4306737) and 5 mL of extracted DNA
template was added to each well. Thermal cycling was
performed on a real-time PCR system (ABI 7500, Applied
Biosystems) using the following thermal profile: 15
minutes at 95°C to activate the HotStarTaq, followed by 40
cycles of 94°C for 30 seconds, and 60°C for 35 seconds.
Three negative controls with EMA-treated PCRmastermix
and no added template were included in each run.
Unsheared Escherichia coli DNA (Sigma-Aldrich Ltd,
Poole, Dorset, UK; catalogue no. D4889) diluted in 0.1%
Triton X-100was included as a positive control in each run
at dilutions corresponding to approximately 5000, 500, 50,
and five genome copies per PCR procedure.
BacT/ALERT automated culture and
bacterial identification
The BacT/ALERT continuous monitoring system, based
on the detection of CO2 produced by bacteria, was used
according to manufacturer’s instructions. Bottles were
inoculated with 8-mL aliquots of PLT concentrates and
incubated at 36°C in both aerobic and anaerobic condi-
tions until the end of the PLT shelf life, that is, 7 days
postdonation. Identification of positive BacT/ALERT cul-
tures was performed using conventional bacteriologic
techniques.
GARSON ET AL.
872 TRANSFUSION Volume 54, March 2014
RESULTS
Sensitivity of PCR assay and threshold setting for
PLT screening
The sensitivity of the EMA-enhanced 16S rDNA real-time
PCR was confirmed in each assay run with a 10-fold dilu-
tion series of E. coli DNA representing 5000, 500, 50, and
five genome copies per reaction. Typical results are illus-
trated in Fig. 1A, which shows that five genome copies are
readily detected and clearly distinguishable from the three
no-template controls (NTCs). For initial experiments the
threshold was set at a level that was intersected by the
five-genome-copy control at 40 cycles. However, it soon
became apparent that this five-genome-copy threshold
level was too low for screening PLTs because a significant
proportion of them contained bacterial DNA at or around
this level, as illustrated in Fig. 1B. The spreading fan of late
amplification curves referred to as “background noise” in
Fig. 1B was seen in all runs with time-expired PLTs (2050
samples tested in 23 separate PCR procedures) and the
same phenomenon was observed on testing the 176 fresh
PLT packs. Approximately 7% of all PLT packs tested con-
tained bacterial DNA at a concentration that crossed the
five-genome-copy threshold level, typically betweenCycle
Fig. 1. (A) Typical dilution series of 5000, 500, 50, and five E. coli genome copies per PCR procedure and three NTCs. Threshold in
this case was set at the subsequently abandoned five-copy level. The horizontal axis indicates cycle number and the vertical axis
indicates fluorescence (Delta Rn). (B) The same experimental run as illustrated in A but with curves from eight PLT concentrates
added. Note typical spreading fan of late amplification curves, one of which crosses the five-copy threshold. The horizontal axis
indicates cycle number and the vertical axis indicates fluorescence (Delta Rn).
PLT SCREENING BY 16S PCR AND BACT/ALERT
Volume 54, March 2014 TRANSFUSION 873
38 and Cycle 40 (equivalent to between 20 and five
genome copies per reaction). In contrast, amplification
signals were not seen with NTCs or with extraction buffer–
negative controls extracted in parallel through theMagNA
Pure 96 system.
In view of these findings the threshold for screening
PLTs was raised to a level slightly higher than that of the
“background noise.” The threshold was therefore set in
each PLT screening run so that it was intersected by the
50-genome-copy control at Cycle 39 (equivalent to a
detection limit of 25 genome copies per reaction in a
40-cycle PCR procedure). This modified threshold level
was used for the analysis of all the PCR data presented in
this study.
Comparison of PCR and BacT/ALERT results on
time-expired PLT concentrates
All time-expired PLTs were tested by EMA-enhanced 16S
rDNA real-time PCR and in parallel by the BacT/ALERT
automated culture system. On first testing by PCR, 23
(1.12%) of the 2050 time-expired PLT concentrates gener-
ated a positive 16S signal, that is, above the modified
threshold level, with threshold cycle (Ct) values between
Cycle 38 and Cycle 40. Only seven (0.34%) of these were
found to be positive on repeat PCR testing of the first
nucleic acid extract, also with Ct values between 38 and
40. However, none of the seven was subsequently con-
firmed positive by reextraction and PCR testing of frozen
stored second aliquots. BacT/ALERT testing of the 2050
time-expired PLT concentrates also failed to find any
which were confirmed positive on repeat testing although
0.24% were reported reactive on the first test.
Comparison of PCR and BacT/ALERT results on
initial-reactive PLT concentrates
Four-hundred initial-reactive PLT packs were transferred
from regional testing centers to Colindale for testing by
both methods. Twelve of the 400 initial-reactive PLTs gave
a positive 16S signal on first testing by PCR and three of
the 12 were also positive on repeat testing of the first
nucleic acid extract. The Ct values of the remaining nine
samples that were not confirmed positive on repeat
testing of the first extract were within the range 38 to 40
cycles on initial PCR testing. The three repeat-reactive
samples were confirmed 16S PCR positive after reextrac-
tion of the frozen stored second aliquots (Fig. 2). The same
three initial-reactive PLT concentrates were also con-
firmed positive by BacT/ALERT on testing and retesting,
the contaminating bacteria being identified as E. coli,
Streptococcus vestibularis, and Listeria monocytogenes
(Table 2).
An additional 14 initial-reactive PLT concentrates
were confirmed positive by BacT/ALERT testing only
(Table 2). In 13 of these cases the contaminating organ-
ismswere identified as anaerobic skin or oral commensals
including Propionibacterium acnes (n = 6) and Streptococ-
cus oralis. In the remaining case the contaminating organ-
ism, detected after 14.2-hour BacT/ALERT incubation,
was identified as Streptococcus pneumoniae. The failure of
the 16S PCR to detect this organism was found not to be
due to sequence mismatch because the cultured isolate
was readily detected in subsequent experiments (data not
shown). Furthermore, the failure of the 16S PCR to detect
P. acnes, Staphylococcus saccharolyticus, Streptococcus
salivarius, S. oralis, and coagulase-negative Staphylococ-
cus in these PLT packs was not due to sequence mismatch
since BLAST analysis revealed perfect alignment of the
oligonucleotide primers and probes with all these organ-
isms. Note that all 17 repeat-positive BacT/ALERT results
were confirmed by culturing the same organism from the
original PLT pack and the initial-reactive BacT/ALERT
bottle.
Performance of the human mtDNA internal control
To confirm efficient nucleic acid extraction, efficient
amplification, and absence of PCR inhibitors, human
mtDNAwas coamplified in each reaction and served as an
internal control. Ct values generated by the mtDNA PCR
typically fell within the range 19 to 24 cycles. Delayed
mtDNA amplification signals (>mean Ct + 3.5 SD) were
observed in approximately 0.5% of the 2626 PLT concen-
trates tested. In every instance (other than delay caused by
competition from very high 16S PCR signals; see Fig. 3)
in which a delayed mtDNA amplification signal was
observed, the PCR was repeated on the original nucleic
acid extract and the mtDNA signal returned to within the
expected Ct range.
DISCUSSION
The behavior of the EMA-enhanced 16S rDNA real-time
PCR assay in this present studywas essentially the same as
reported previously.24 However, the observation that PLT
packs commonly contain trace amounts of bacterial DNA
(Fig. 1B) necessitated increasing the assay threshold level
to 25 genome copies per PCR procedure for the purposes
of PLT screening. This low-level bacterial DNA, referred to
here as “background noise,” is thought to be due to bac-
terial DNA fragments or nonviable organisms because it
was present at the same level in both fresh and time-
expired PLT concentrates. If viable organisms had been
responsible, the “background noise” would have been
expected to be higher in time-expired concentrates that
had been stored at 22°C for 7 days. The presence of bacte-
rial DNA fragments, detected by 16S rDNA PCR, in blood
from healthy individuals has been noted previously.26,27
The results obtained from screening 2050 time-
expired PLT packs by EMA-enhanced 16S rDNA real-time
GARSON ET AL.
874 TRANSFUSION Volume 54, March 2014
PCR were in agreement with those generated by BacT/
ALERT in that no sample was confirmed positive in either
assay. The observed low prevalence of bacterial contami-
nation (<0.048%) in these PLT concentrates is consistent
with recent reports from other countries28,29 and confirms
the efficacy of improved donor skin disinfection and
diversion techniques.30
Not surprisingly, the prevalence of confirmed bacte-
rial contamination in the initial-reactive PLT concentrates
(17 of 400 [4.2%] by BacT/ALERT) was significantly higher
than in the time-expired PLTs. A wide range of incubation
times (3.6-132 hr) was required before the BacT/ALERT
automated culture system flagged these PLT concentrates
as reactive. It is noteworthy that the three packs with the
shortest incubation times (all 10 hr) were the three that
were also detected by the 16S rDNA real-time PCR assay
and are likely to have been the PLT packs with the highest
bacterial concentrations.
The remaining 14 PLT concentrates, confirmed posi-
tive by BacT/ALERT but undetected by PCR required
longer incubation times (associated with lower bacterial
concentrations and/or more slowly replicating organ-
isms) before being flagged as reactive. With the exception
of S. pneumoniae, the organisms isolated from these PCR-
Fig. 2. (A) Amplification curves from two of the three contaminated initial-reactive PLT concentrates (retesting of the first PCR
extracts). Samples from the E. coli-contaminated pack at 1:50 dilution and from the S. vestibularis-contaminated pack are shown.
The 500-, 50-, and five-copy standards are also illustrated together with three NTCs. The horizontal axis indicates cycle number and
the vertical axis indicates fluorescence (Delta Rn). (B) The L. monocytogenes-contaminated PLT concentrate exhibiting a Ct of
approximately 25 cycles on testing of the second nucleic acid extract. The horizontal axis indicates cycle number and the vertical
axis indicates fluorescence (Delta Rn). Note that the threshold is set at the 25-copy level.
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negative packs are considered unlikely, especially at such
low concentrations, to have resulted in significant harm to
recipients.31-33 However, it is important to acknowledge 1)
that the assumption of lowbacterial concentration in such
packs is based on inference rather than on directmeasure-
ment and 2) that our opinion concerning the improbabil-
ity of harm to recipients in such cases is less certain for
S. salivarius and S. oralis than it is for P. acnes and S. sac-
charolyticus, which have been shown not to proliferate in
PLT packs.31-33 Reassuringly, for coagulase-negative Sta-
phylococcus, Koopman and colleagues32 have recently
reported that none of 33 recipients transfused with con-
taminated PLT packs experienced adverse reactions. Due
to the long incubation periods (9 of 14 required > 54 hr
incubation) and the policy of release on a “negative-to-
date” basis, contaminated PLT packs such as thesemay be
transfused before being flagged as reactive by BacT/
ALERT, although this did not occur in this study.
S. pneumoniae is potentially highly pathogenic and it
is therefore important to understand why it was not
detected by 16S PCR in this case. There was no evidence of
primer or probe sequence mismatch because the subcul-
tured isolate was readily detected by the PCR assay in
subsequent experiments. In our previous studies24 we
demonstrated that the lower limit of detection by 16S PCR
for S. pneumoniae is approximately 10 CFUs/mL and that
the corresponding incubation time for BacT/ALERT at this
level is approximately 13 hours. It therefore seems prob-
able that the bacterial concentration in the contaminated
pack was just below the limit of detection by PCR because
the time taken for BacT/ALERT to flag reactive was 14.2
hours in this instance.
It is clear from these findings and from the findings of
earlier studies24,34 that the analytical sensitivity of 16S PCR
is lower than that of the BacT/ALERT automated culture
system. The sensitivity difference is assumed chiefly to be
TABLE 2. Details of bacterially contaminated PLT packs detected by 16S rDNA PCR and/or by
BacT/ALERT testing
Number of
packs* Organism isolated
BacT/ALERT result
(incubation time†)
16S rDNA PCR
result (Ct)
1 E. coli Positive (3.6 hr) Positive (23 cycles‡)
1 L. monocytogenes Positive (7.3 hr) Positive (25 cycles)
1 S. vestibularis Positive (10 hr) Positive (37 cycles)
6 P. acnes Positive (74-132 hr) Negative
3 S. saccharolyticus Positive (54-65 hr) Negative
1 S. salivarius Positive (14.3 hr) Negative
1 S. oralis Positive (13.5 hr) Negative
2 Coagulase-negative Staphylococcus Positive (18-25 hr) Negative
1 S. pneumoniae Positive (14.2 hr) Negative
* Note that none of the PLT packs listed in this table were actually transfused.
† Incubation time = time until positive reaction signaled.
‡ Ct of 23 cycles obtained with E. coli-contaminated sample diluted 1:50.
Fig. 3. Example of delayed mtDNA amplification, in this case caused by competition from a very high L. monocytogenes 16S signal.
The horizontal axis indicates cycle number and the vertical axis indicates fluorescence (Delta Rn).
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due to the 40- to 80-fold greater sample volume used by
the BacT/ALERT system (8 mL per culture bottle vs.
0.2 mL per PCR procedure, thus 80-fold if both aerobic
and anaerobic cultures are performed) and to the fact that
organisms can replicate in culture bottles for several days
until they become detectable. The inability to run the PCR
assay with a low detection threshold because of the pres-
ence of bacterial DNA fragments in blood from healthy
donors further increases the sensitivity difference
between the two assays. However, the lower sensitivity of
16S PCR may not be a problem in practice because, being
a rapid assay (~4 hr), testing can be delayed so that bacte-
rial growth on PLT storage would potentially negate the
sensitivity disadvantage. Rapid 16S PCR assays such as the
one described here may therefore be more suited to a
strategy of late or prerelease testing as proposed by Dreier
and colleagues.13 The feasibility of such a late testing strat-
egy in which a rapid real-time PCR-based assay would be
employed after an approximately 48-hour holding period
to allow bacterial replication has recently been demon-
strated.9 This strategy, in principle, would allow PLTs to be
issued as “negative” instead of negative to date.34 Alterna-
tively, a prerelease strategy could be employed in which
PCR-based testing would be performed immediately
before transfusion, but the current approximately 4-hour
duration of the assay would have to be reduced consider-
ably to make this a practicable option. Such strategies
could help reduce unnecessary recalls because organisms
that do not proliferate in stored PLTs (e.g., P. acnes and
S. saccharolyticus) would not be detected.31,33
In conclusion, this study confirms that EMA treat-
ment is an effective solution to the previously intractable
problem of bacterial DNA contamination in PCR reagents
and that an EMA-enhanced real-time 16S PCR assay is
capable of screening PLT concentrates without generating
false-positive results. The study also demonstrates clearly
that the sensitivity of such PCR assays is insufficient for
use in early testing strategies, that is, as an alternative to
automated culture systems such as BacT/ALERT. Future
studies are being planned to evaluate the efficacy of this
EMA-enhanced real-time 16S PCR assay in late or pre-
release testing strategies.
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